At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 103 enrolled
Drug / intervention
Blood Collectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Exploratory, Multi-Center, Open-Label, Single-Arm Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent (DECADES) on Inflammatory and Platelet Activation Markers in Subjects Who Are Receiving Low Dose Acetylsalicylic Acid (ASA)
In Brief
A Phase 4 clinical trial evaluating Blood Collection for Antiplatelet Aggregation. Completed, enrolled 103 participants across 6 sites in 4 countries.
Detailed Summary
The purpose of the study is to look at the biomarkers of inflammation and platelet activation in patients with drug eluting stents implanted approximately 12 months ago on aspirin and statin, for a 4-week period after the routine discontinuation of clopidogrel
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAntiplatelet Aggregation
CountriesFrance, Germany, Netherlands, United Kingdom
CollaboratorsSanofi
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2007
Enrollment StartOct 2007
Primary CompletionJun 2008
TodayJul 2026
First PostedJun 28, 2007
Enrollment StartOct 1, 2007
Primary CompletionJun 1, 2008
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 19.0 years ago
Interventions
Blood Collectionprocedure
4 weeks